Jefferies downgrades rating to "hold" on NZ's Fisher & Paykel Healthcare

Fisher & Paykel Healthcare

22/05/2025 20:04

** Analysts at Jefferies downgrade rating to "hold" from "buy" on New Zealand's Fisher & Paykel Healthcare FPH.NZ

** Jefferies says it is interested in knowing the impacts FPH has faced from U.S. tariffs to date, when it reports FY25 results on May 28; to keep a close eye on co's mitigation strategies

** However, brokerage keeps PT unchanged at NZ$39.40 per share

** We understand the primary impact on FPH imports is currently a 10% tariff on New Zealand products — brokerage

** One of 12 analysts rate the stock "buy" or higher, nine "hold" and two "sell" or lower; their median PT is NZ$35.81, according to data compiled by LSEG

** Stock has fallen 4.3% this year, as of last close

(Reporting by Roshan Thomas in Bengaluru)

((Roshan.Thomas@thomsonreuters.com))